Magnesium citrate - RMJ Holdings

Drug Profile

Magnesium citrate - RMJ Holdings

Alternative Names: RMJH 111b

Latest Information Update: 12 Jul 2016

Price : $50

At a glance

  • Originator RMJ Holdings
  • Class Laxatives
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Hypertension

Most Recent Events

  • 01 Jun 2016 Phase-I/II clinical trials in Hypertension in USA (PO) (NCT02822222)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top